Robust CNS regeneration after complete spinal cord transection using aligned poly-L-lactic acid microfibers
Andres Hurtado1, Jared M Cregg, Han B Wang
1International Center for Spinal Cord Injury, Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD 21205, USA. hurtado@kennedykrieger.org
Biomaterials
|June 4, 2011
Summary
Aligned microfiber grafts promote significant axonal regeneration after spinal cord injury. This breakthrough in central nervous system (CNS) regeneration biology offers new hope for recovery.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Biomaterials Science
Background:
- Axonal regeneration is limited following spinal cord injury without intervention.
- Developing effective strategies for central nervous system (CNS) repair is crucial.
Purpose of the Study:
- To investigate the efficacy of aligned microfiber-based grafts in promoting CNS tissue regeneration.
- To compare the regenerative potential of aligned, random, and film microfiber conduits in a rat spinal cord injury model.
Main Methods:
- Grafting of aligned, random, and film poly-L-lactic acid microfiber conduits into a 3 mm thoracic spinal cord gap in rats.
- Assessment of tissue infiltration, gap closure, axonal regeneration, and astrocyte alignment over 4 weeks.
- Retrograde tracing to identify the origin of regenerating axons.
Main Results:
- Aligned and random microfibers facilitated host tissue infiltration and gap closure by endogenous cells.
- Aligned microfiber grafts supported significantly greater long-distance axonal regeneration (2055 ± 150 µm) compared to random (1162 ± 87 µm) and film (413 ± 199 µm) conduits.
- Regenerating axons originated from propriospinal and supraspinal neurons.
Conclusions:
- Aligned microfiber-based grafts are effective in fostering robust regeneration of vascularized CNS tissue.
- The microtopography of aligned fibers plays a critical role in guiding long-distance axonal regeneration.
- These findings have significant implications for regeneration biology and the development of therapies for spinal cord injury.


